Axon Enterprise director granted 600-share RSU award

MOHINDRA VIVEK reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

MOHINDRA VIVEK reported acquisition or exercise transactions in this Form 4 filing.

Axon Enterprise, Inc. director Vivek Mohindra reported an equity compensation grant of 600 shares of common stock through time-vested restricted stock units under the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. The award was granted at $0.00 per share and is scheduled to vest in three equal installments beginning on July 8, 2027, subject to the plan’s terms.

Insider Trade Summary

Grant/Award: 600 shares

Grant/Award 1 txn

Insider MOHINDRA VIVEK

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	600	$0.00	$0.00

Holdings After Transaction: Common Stock — 600 shares (Direct)

Footnotes (1)

1. F1. Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. The grant is scheduled to vest in three equal installments beginning on July 8, 2027.

Key Figures

Shares granted: 600 shares Grant price per share: $0.00 per share Installments: 3 equal installments +2 more

5 metrics

Shares granted 600 shares Time-vested restricted stock units granted to the director

Grant price per share $0.00 per share Equity compensation award, not an open-market purchase

Installments 3 equal installments Vesting schedule for the restricted stock unit grant

First vesting date July 8, 2027 Initial vesting date for the RSU award

Shares held after transaction 600 shares Total direct holdings listed following the grant

Key Terms

time-vested restricted stock units, Amended and Restated 2022 Stock Incentive Plan, vest in three equal installments

3 terms

time-vested restricted stock units financial

"Time-vested restricted stock units granted to the reporting person pursuant"

Amended and Restated 2022 Stock Incentive Plan financial

"pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan"

vest in three equal installments financial

"The grant is scheduled to vest in three equal installments beginning"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Axon (AXON) director Vivek Mohindra report in this Form 4?

Director Vivek Mohindra reported a grant of 600 shares of Axon common stock in the form of time-vested restricted stock units, awarded as equity compensation under Axon’s Amended and Restated 2022 Stock Incentive Plan.

How many Axon (AXON) shares were granted to Vivek Mohindra and at what price?

Vivek Mohindra was granted 600 shares of Axon common stock at a grant price of $0.00 per share, reflecting a stock-based compensation award rather than an open-market purchase.

What is the vesting schedule for Vivek Mohindra’s Axon (AXON) restricted stock units?

The 600 time-vested restricted stock units are scheduled to vest in three equal installments, beginning on July 8, 2027, according to the footnote describing the award terms.

How many Axon (AXON) shares does Vivek Mohindra hold after this reported transaction?

Following the reported grant, Vivek Mohindra’s direct holdings are listed as 600 shares of Axon common stock, reflecting the full amount of the awarded restricted stock units.

Is Vivek Mohindra’s Axon (AXON) Form 4 transaction an open-market buy or a compensation award?

The Form 4 reports a grant/award acquisition of restricted stock units, not an open-market purchase, with transaction code A indicating an equity compensation award to the director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/10/2026 - 04:29 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MOHINDRA VIVEK

(Last) (First) (Middle)

17800 NORTH 85TH STREET

(Street)

SCOTTSDALE ARIZONA 85255

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/08/2026		A		600(1)	A	$0	600	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. The grant is scheduled to vest in three equal installments beginning on July 8, 2027.

Remarks:

	/s/ Vivek Mohindra by Isaiah Fields, Attorney-in-Fact	07/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)